Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus. She is the Principal Investigator on a number of large global studies in the field of diabetes, obesity, physical activity, sedentary behaviour and cardiovascular disease. The COVID-19 pandemic particularly impacts on people with cardiometabolic multimorbidity – those patients who have two or more of heart disease, stroke or diabetes. There is a higher risk still for people with type 2 diabetes and obesity who are from BAME groups.